C34, a Membrane Fusion Inhibitor, Blocks HIV Infection of Langerhans Cells and Viral Transmission to T Cells
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (6) , 1436-1443
- https://doi.org/10.1038/sj.jid.5700736
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitorsProceedings of the National Academy of Sciences, 2004
- In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 TransmissionAntimicrobial Agents and Chemotherapy, 2004
- Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and CJournal of Virology, 2003
- Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic CellsJournal of Virology, 2000
- DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T CellsPublished by Elsevier ,2000
- Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetProceedings of the National Academy of Sciences, 1998
- Capture of an early fusion-active conformation of HIV-1 gp41Nature Structural & Molecular Biology, 1998
- Core Structure of gp41 from the HIV Envelope GlycoproteinPublished by Elsevier ,1997
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996